-
1
-
-
74149085154
-
The epidemiology of dementia associated with Parkinson disease
-
Aarsland D, Kurz MW. The epidemiology of dementia associated with Parkinson disease. J Neurol Sci 2010;289:18-22.
-
(2010)
J Neurol Sci
, vol.289
, pp. 18-22
-
-
Aarsland, D.1
Kurz, M.W.2
-
2
-
-
27644456601
-
Neuropathology of dementia in Parkinson's disease: A prospective, community-based study
-
DOI 10.1002/ana.20635
-
Aarsland D, Perry R, Brown A, Larsen JP, Ballard C. Neuropathology of dementia in Parkinson's disease: A prospective, community-based study. Ann Neurol 2005;58:773-776. (Pubitemid 41552553)
-
(2005)
Annals of Neurology
, vol.58
, Issue.5
, pp. 773-776
-
-
Aarsland, D.1
Perry, R.2
Brown, A.3
Larsen, J.P.4
Ballard, C.5
-
3
-
-
70350319531
-
Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease
-
Sidransky E, Nalls MA, Aasly JO, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med 2009;361:1651-1661.
-
(2009)
N Engl J Med
, vol.361
, pp. 1651-1661
-
-
Sidransky, E.1
Nalls, M.A.2
Aasly, J.O.3
-
4
-
-
66249129677
-
Association of glucocerebrosidase mutations with dementia with Lewy bodies
-
Clark LN, Kartsaklis LA, Wolf GR, et al. Association of glucocerebrosidase mutations with dementia with Lewy bodies. Arch Neurol 2009;66:578-583.
-
(2009)
Arch Neurol
, vol.66
, pp. 578-583
-
-
Clark, L.N.1
Kartsaklis, L.A.2
Wolf, G.R.3
-
5
-
-
67650087652
-
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease
-
Neumann J, Bras J, Deas E, et al. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. Brain 2009;132:1783-1794.
-
(2009)
Brain
, vol.132
, pp. 1783-1794
-
-
Neumann, J.1
Bras, J.2
Deas, E.3
-
6
-
-
80051481698
-
GBAassociated PD presents with nonmotor characteristics
-
Brockmann K, Srulijes K, Hauser AK, et al. GBAassociated PD presents with nonmotor characteristics. Neurology 2011;77:276-280.
-
(2011)
Neurology
, vol.77
, pp. 276-280
-
-
Brockmann, K.1
Srulijes, K.2
Hauser, A.K.3
-
7
-
-
0030581111
-
Lewy bodies are located preferentially in limbic areas in diffuse Lewy body disease
-
DOI 10.1016/0304-3940(96)12775-0
-
Rezaie P, Cairns NJ, Chadwick A, Lantos PL. Lewy bodies are located preferentially in limbic areas in diffuse Lewy body disease. Neurosci Lett 1996;212:111-114. (Pubitemid 26298553)
-
(1996)
Neuroscience Letters
, vol.212
, Issue.2
, pp. 111-114
-
-
Rezaie, P.1
Cairns, N.J.2
Chadwick, A.3
Lantos, P.L.4
-
8
-
-
84860708754
-
Cognitive performance of GBA mutation carriers with earlyonset PD: The CORE-PD study
-
Alcalay RN, Caccappolo E, Mejia-Santana H, et al. Cognitive performance of GBA mutation carriers with earlyonset PD: The CORE-PD study. Neurology 2012;78: 1434-1440.
-
(2012)
Neurology
, vol.78
, pp. 1434-1440
-
-
Alcalay, R.N.1
Caccappolo, E.2
Mejia-Santana, H.3
-
9
-
-
53049096591
-
Phenotype, diagnosis, and treatment of Gaucher's disease
-
Grabowski GA. Phenotype, diagnosis, and treatment of Gaucher's disease. Lancet 2008;372:1263-1271.
-
(2008)
Lancet
, vol.372
, pp. 1263-1271
-
-
Grabowski, G.A.1
-
10
-
-
79961083395
-
CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy
-
Sardi SP, Clarke J, Kinnecom C, et al. CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy. Proc Natl Acad Sci USA 2011;108:12101-12106.
-
(2011)
Proc Natl Acad Sci USA
, vol.108
, pp. 12101-12106
-
-
Sardi, S.P.1
Clarke, J.2
Kinnecom, C.3
|